Viracta Therapeutics Stock Technical Analysis
| VIRX Stock | USD 0.16 0.01 6.67% |
As of the 25th of November, Viracta Therapeutics has the Coefficient Of Variation of (584.97), variance of 21.36, and Risk Adjusted Performance of (0.12). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Viracta Therapeutics, as well as the relationship between them.
Viracta Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Viracta, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ViractaViracta |
Viracta Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.75 | Hold | 1 | Odds |
Most Viracta analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Viracta stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Viracta Therapeutics, talking to its executives and customers, or listening to Viracta conference calls.
Viracta Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Viracta Therapeutics Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Viracta Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Viracta Therapeutics Trend Analysis
Use this graph to draw trend lines for Viracta Therapeutics. You can use it to identify possible trend reversals for Viracta Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Viracta Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Viracta Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Viracta Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.0013 , which may suggest that Viracta Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.06, which is the sum of squared deviations for the predicted Viracta Therapeutics price change compared to its average price change.About Viracta Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Viracta Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Viracta Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Viracta Therapeutics price pattern first instead of the macroeconomic environment surrounding Viracta Therapeutics. By analyzing Viracta Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Viracta Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Viracta Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 (projected) | Interest Debt Per Share | 0.76 | 0.72 | Revenue Per Share | 1.49 | 1.41 |
Viracta Therapeutics November 25, 2024 Technical Indicators
Most technical analysis of Viracta help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Viracta from various momentum indicators to cycle indicators. When you analyze Viracta charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.12) | |||
| Market Risk Adjusted Performance | 0.6055 | |||
| Mean Deviation | 3.21 | |||
| Coefficient Of Variation | (584.97) | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.36 | |||
| Information Ratio | (0.20) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (1.53) | |||
| Treynor Ratio | 0.5955 | |||
| Maximum Drawdown | 25.82 | |||
| Value At Risk | (8.00) | |||
| Potential Upside | 5.26 | |||
| Skewness | (0.16) | |||
| Kurtosis | 2.29 |
Additional Tools for Viracta Stock Analysis
When running Viracta Therapeutics' price analysis, check to measure Viracta Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viracta Therapeutics is operating at the current time. Most of Viracta Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viracta Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viracta Therapeutics' price. Additionally, you may evaluate how the addition of Viracta Therapeutics to your portfolios can decrease your overall portfolio volatility.